Has Jawad Haider, MD received payments from drug or device companies?

Yes. Drug and device makers reported $373,062 in general payments to Jawad Haider, MD across 692 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jawad Haider, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jawad Haider, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jawad Haider, MD

Interventional Cardiology · Bloomfield, CTNPI 1194773564

Payments from drug & device makers

$373,062in general payments, 2019–2025

Across 692 payments — averaging $539.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$334K
AstraZeneca$19K
Abbott$7K
Boston Scientific$6K
Medtronic$2K
Baylis Medical Company Inc$1K
plus $5K from 34 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	175	$334,182
AstraZeneca	48	$18,617
Abbott	93	$6,859
Boston Scientific	102	$5,606
Medtronic(2 entities)	53	$1,663
Baylis Medical Company Inc	5	$1,024
Medical Device Business Services, Inc.	4	$683
Johnson & Johnson	40	$540
Novartis	23	$451
Amgen	18	$362
Pfizer	27	$347
Boehringer Ingelheim	10	$250
Shockwave Medical, Inc	2	$244
Amarin Pharma, Inc.	13	$240
Heartflow, Inc.	4	$232
Esperion Therapeutics, Inc.	8	$185
Novo Nordisk	8	$153
Terumo Medical Corporation	2	$143
Alnylam Pharmaceuticals Inc.	5	$138
E.r. Squibb & Sons, L.L.C.	9	$137
Cardiovascular Systems Inc.	1	$131
Kowa Pharmaceuticals America, Inc.	9	$120
Actelion Pharmaceuticals US, Inc.	4	$97
Bard Peripheral Vascular, Inc.	1	$76
Sanofi-aventis U.S. LLC	4	$74
Kiniksa Pharmaceuticals International, PLC	2	$73
Bayer	3	$60
Cardiva Medical, Inc.	3	$52
Angiodynamics, Inc.	1	$47
Bardy Diagnostics, Inc.	4	$42
Scpharmaceuticals Inc.	2	$38
Abiomed	1	$32
Irhythm Technologies, Inc.	1	$28
Chiesi USA, Inc.	1	$28
Merck	1	$21
Penumbra, Inc.	1	$20
Opsens Inc.	1	$20
Impulse Dynamics (USA) Inc.	1	$19
Preventice Services, LLC	1	$13
Regeneron Healthcare Solutions, Inc.	1	$12

How this compares

$373,062 in reported general payments places this provider in the 90th percentile of 73 interventional cardiology providers in Connecticut.

See all interventional cardiology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$124,437

Medicare patients

269

Services billed

693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Bloomfield

Patrick CorcoranBloomfield$12K
Edward PortnayStamford$2.2M
Hari DeshpandeNew Haven$1.2M
Hal WassermanDanbury$848K
Craig ThompsonHartford$682K
Samit ShahNew Haven$584K
Amit VoraNew Haven$530K
Joseph IngrassiaHartford$387K
Robert AttaranBridgeport$203K
Michael RemetzNew Haven$153K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →